The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomographic Scanning in Patients with Thyroid Cancer
Abstract
Poorly differentiated thyroid cancer lesions often lose the ability to concentrate radioactive [131I]iodine (RAI) and exhibit increased metabolic activity, as evidenced by enhanced glucose uptake. We incorporated [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) scanning into the routine follow-up of a cohort of thyroid cancer patients undergoing annual evaluations. One hundred and twenty-five patients who had previous thyroidectomies were included. They had diagnostic RAI whole body scans, serum thyroglobulin measurements, and additional imaging studies as clinically indicated. During 41 months of follow-up, 14 patients died. Univariate analysis demonstrated that survival was reduced in those with age over 45 yr, distant metastases, PET positivity, high rates of FDG uptake, and high volume of the FDG-avid disease (>125 mL). Survival did not correlate with gender, RAI uptake, initial histology, or grade. Multivariate analysis demonstrated that the single strongest predictor of survival was the volume of FDG-avid disease. The 3-yr survival probability of patients with FDG volumes of 125 mL or less was 0.96 (95% confidence interval, 0.91, 1.0) compared with 0.18 (95% confidence interval, 0.04, 0.85) in patients with FDG volume greater than 125 mL. Only 1 death (of leukemia) occurred in the PET-negative group (n = 66). Of the 10 patients with distant metastases and negative PET scans, all were alive and well. Patients over 45 yr with distant metastases that concentrate FDG are at the highest risk. Once distant metastases are discovered in patients with differentiated thyroid carcinoma, FDG-PET can identify high and low risk subsets. Subjects with a FDG volume greater than 125 mL have significantly reduced short term survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Landis, S. H., Murray, T., Bolden, S., & Wingo, P. A. (1999) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.49.1.8 · Cited by 3,068
Firminger, H. I. (1968) · Armed Forces Institute of Pathology eBooks · Cited by 3,044
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
Mazzaferri, E. L., & Jhiang, S. M. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90321-2 · Cited by 2,635
Hundahl, S. A., Fleming, I. D., Fremgen, A. M., & Menck, H. R. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981215)83:12<2638::aid-cncr31>3.0.co;2-1 · Cited by 1,836
Papillary and Follicular Thyroid Carcinoma
Schlumberger, M. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380506 · Cited by 1,623
HAY, I. D., Bergstralh, E. J., Goellner, J. R., Ebersold, J. R., & Grant, C. S. (1993) · PubMed · Cited by 1,223
An expanded view of risk-group definition in differentiated thyroid carcinoma.
Cady, B., & Rossi, R. (1988) · PubMed · Cited by 937
Gilliland, F. D., Hunt, W. C., Morris, D. M., & Key, C. R. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970201)79:3<564::aid-cncr20>3.0.co;2-0 · Cited by 803
Hay, I. D. (1990) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30310-4 · Cited by 634
Long-term results and prognostic factors in patients with differentiated thyroid carcinoma
Tubiana, M., Schlumberger, M., Rougier, P., Laplanche, A., Benhamou, E., Gardet, P., Caillou, B., Travagli, J.-P., & Parmentier, C. (1985) · Cancer · doi:10.1002/1097-0142(19850215)55:4<794::aid-cncr2820550418>3.0.co;2-z · Cited by 573
Schlumberger, M. J., Vathaire, C. C.-D., de Vathaire, F., Travagli, J. P., Gardet, P., Lumbroso, J., Francese, C., Fontaine, F., Ricard, M., & Parmentier, C. (1996) · PubMed · Cited by 498
Rosaí, J., Carcangiu, M. L., & DeLellis, R. A. (1992) · Armed Forces Institute of Pathology eBooks · Cited by 492
Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding
Erdi, Y. E., Mawlawi, O., Larson, S. M., Imbriaco, M., Yeung, H., Finn, R., & Humm, J. L. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971215)80:12+<2505::aid-cncr24>3.0.co;2-f · Cited by 480
(1962) · PubMed · Cited by 467
Ladenson, P. W., Braverman, L. E., Mazzaferri, E. L., Brucker-Davis, F., Cooper, D. S., Garber, J. R., Wondisford, F. E., Davies, T. F., DeGroot, L. J., Daniels, G. H., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709253371304 · Cited by 466
Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.
Feine, U., Lietzenmayer, R., Hanke, J. P., Held, J., Wöhrle, H., & Müller-Schauenburg, W. (1996) · PubMed · Cited by 390
Ahuja, V., Coleman, R. E., Herndon, J., & Patz, E. F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980901)83:5<918::aid-cncr17>3.0.co;2-y · Cited by 331
Wang, W. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.7.2291 · Cited by 330
Self-citationGrebe, S. K. G., & Hay, I. D. (1995) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30021-5 · Cited by 215
Dietlein, M., Scheidhauer, K., Voth, E., Theissen, P., & Schicha, H. (1997) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050158 · Cited by 195
Grünwald, F., Menzel, C., Bender, H., PALMEDO, H., Willkomm, P., Ruhlmann, J., FRANCKSON, T., & BIERSACK, H.-J. (1997) · Thyroid · doi:10.1089/thy.1997.7.327 · Cited by 149
Leeper, R. D. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-36-6-1143 · Cited by 144
Ain, K. B. (1995) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30020-3 · Cited by 134
Prognostic importance of various clinicopathological features in papillary thyroid carcinoma
Akslen, L. A., Myking, A. O., Salvesen, H. B., & Varhaug, J. E. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90574-y · Cited by 101
Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors.
Uematsu, H., Sadato, N., Ohtsubo, T., Tsuchida, T., Nakamura, S., Sugimoto, K., Waki, A., Takahashi, N., Yonekura, Y., Tsuda, G., et al. (1998) · PubMed · Cited by 89
Prognostic factors in papillary carcinoma of the thyroid
Schindler, A.-M., van Melle, G., Evequoz, B., & Scazziga, B. (1991) · Cancer · doi:10.1002/1097-0142(19910715)68:2<324::aid-cncr2820680220>3.0.co;2-s · Cited by 84
Resampling Procedures to Compare Two Survival Distributions in the Presence of Right-Censored Data
Heller, G., & Venkatraman, E. S. (1996) · Biometrics · doi:10.2307/2532836 · Cited by 65
Cited by
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Sherman, S. I., & Tuttle, R. M. (2006) · Thyroid · doi:10.1089/thy.2006.16.109 · Cited by 2,016
Guidelines for the management of thyroid cancer
Perros, P., Boelaert, K., Colley, S., Evans, C., Evans, R. M., Gerrard BA, G., Gilbert, J., Harrison, B., Johnson, S. J., Giles, T. E., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12515 · Cited by 1,372
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
Kelloff, G. J., Hoffman, J. M., Johnson, B., Scher, H. I., Siegel, B. A., Cheng, E. Y., Cheson, B. D., O'Shaughnessy, J., Guyton, K. Z., Mankoff, D. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2626 · Cited by 671
Metadata
- Authors
- Wang, W.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2000-03-01
- Volume
- 85
- Issue
- 3
- Pages
- 1107-1113
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2104182459
- Cited by
- 339
- References
- 30
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.